Skip to main content

March 9th - Morning workshops

0900-1100

Conference Workshop 1 – PPP authorisation management system (PPPAMS) training session (Chair: Aurélie Dhaussy, ECPA)

0900

Welcome by Chairman

0910

Presentation of system

1000

Interactive question and answer session

1050

Conclusions

1100

Coffee break

0900-1100

Conference Workshop 2 –Market update and agronomic and economic impact of current legislation (Chair: Angel Martin, Dow)

0900

Welcome by Chairman

0910

Resistance management strategies in the EU and the impact of the EU legislation on the availability of solutions - Prof. Lin Field, Rothamsted, UK

0940

Agronomic and economic impact of EU crop protection legislation – Hedda Eggeling & Willem Ruster, Steward Redqueen

1010

Using data to support industry’s political outreach – Graeme Taylor, ECPA

1030

Question & Answer session

1100

Coffee break


March 9th - Main Conference

from

Until

1130

1245

Opening session (Chairman – Hans Mattaar)

1130

1140

Welcome by Chairman

1140

1200

Introductory comments by ECPA

Crop protection industry outlook

Beyond regulation: focus on stewardship efforts

Medium term ‘needs’ for an innovative sector

Jean-Charles Bocquet, ECPA Director General

1200

1230

Dutch Presidency view: The promotion of Sustainable Plant Protection

Dutch “Green deal” initiative

Initiatives in the EU working group on sustainable plant protection

Role of “low-risk” PPPs in European agriculture

Dutch national view on review of Regulations 1107/2009 & 396/2005

Dr Susanne Sütterlin, Ministry of Economic Affairs, Netherlands

1230

1245

Question and answer session

1245

1345

Lunch

1345

1830

Session 1: Major legislative challenges for the crop protection industry

1345

1410

Status update on key elements in the implementation of Regulation 1107/2009

Key Challenges in the legislative implementation

Milestones for 2016

Reviewing Regulations 1107/2009 & 396/2005

Wolfgang Reinert, DG SANTE

1410

1430

Regulation 1107/2009: Lessons learnt after 5 years?

The challenges for legislative implementation in Germany

What are the opportunities to shape and improve current implementation

Possible future improvements through legislative changes

Martin Streloke, BVL, Germany

1430

1450

Food & Veterinary Office view on implementation of Regulation 1107/2009

The role of the Food and Veterinary office in implementing PPP legislation

Experience gained from the national inspections

Areas for improvement – applying and amending the legislation

Dara O’Shea, Food & Veterinary Office, DG SANTE

1450

1510

Review of 1107/2009: Industry view on future improvement options

Key blockers for the generic industry

Suggestions for future improvements

Garth Drury, Rotam CropSciences

1510

1530

EU Minor Uses Coordination Facility

History of the management of minor uses in the EU

The current status of the Minor Use Coordination Facility

Medium-term focus of minor use work

Jeroen Meeussen

1530

1600

Panel discussion

1600

1630

Coffee break

1630

1700

EFSA’s role in the evaluation of active substances

Current evaluations and timelines

Evaluation of new active substances

Main issues identified in the evaluation of AIR-2 active substances

Future challenges with AIR-3, AIR-4 and new ASs

José Tarazona, EFSA

1700

1720

Decision making for new and review active substances

Current status of decision making

Main blockers to decision making

Possible future developments

Mark Williams, DG SANTE

1720

1740

Dealing with the (re)classification of active substances in the EU process

Why has classification become more important in the approval process

Alignment of the PPP approval and CLH processes

How can we make this work

How can industry respond to improve the system

Andrea Caitens, HSE-CRD, UK

1740

1800

The regulatory challenges for industry

The main focus areas and blockers in the regulatory process

Requirements to improve the functioning of the legislation

Active substance decision making – medium term process improvements

Martyn Griffiths, Bayer

1800

1830

Panel discussion

1830

1900

End of session 1; Drinks sponsored by

1900

2000

Political discussion session

1900

1930

Better Regulation and the future of crop protection in Europe

  • Linda-Jean Cockcroft, Risk-Policy Analysts
  • Jarlath Hynes, Humane Society International
  • Paul Leonard, BASF

1930

2000

Questions and answers with the floor

2000

Close

2015

Conference Dinner


March 10th - Main Conference

0830

1230

Session 2: Product authorisation issues

0830

0835

Introduction by the chair

0835

0900

Feedback from the Dublin Workshop & PAIG group

Main conclusions of Dublin workshop

Key follow-up issues and opportunities

Main elements to improve the functioning of the zonal system

Anne-Marie Dillon, Ireland

0900

0920

The zonal experience of the crop protection industry

What progress has been made in improving implementation?

Further areas for improvement in the process

Dealing with Article 43 – issues and options

Sibylle Brosius, BASF

0920

0940

Mission impossible: Early learning in managing Article 43 implementation

A reminder of the provisions on Article 43

The current guidance to support the process

Remaining issues for evaluators – and some possible solutions

Christian Prohaska, AGES, Austria

0940

1035

Discussion on Article 43 with representatives of the zones

  • North – Vibeke Møller, Denmark
  • South – Chara Panagopoulou, Greece

1035

1100

Coffee

1100

1120

Managing the legislative complexity to maintain product availability

The key challenges of product availability

Mutual Recognition and product availability

Workable implementation of comparative assessment

Guidance documents – A help or a hindrance to the zonal system?

Miriam Cavaco, DGAV/DSMDS, Portugal

1120

1140

Challenges and specific developments to support the zonal system:

  • Efficacy – national, zonal or EU approaches?
  • How does comparative assessment fit in the system
  • Guidance to support seed treatment applications

Maarten Trybou, Belgium

1140

1200

Evaluator view: Is industry adapting to the zonal system?

  • The impact of the zonal system on industry submissions
  • Submission quality – are improvements possible?
  • New challenges on the horizon that need to be considered.

Pavel Minar, Czech Republic

1200

1250

Panel discussion with:

  • Peter Schlotter, Dow
  • Darren Flynn, CRD

1250

1400

Lunch

1400

1600

Session 3: Scientific developments: Guidance documents, Endocrine Disruptors and the evolving science of testing

1400

1420

Challenges of the bee risk assessment in product (re)authorisation

  • Overview of current data requirements and guidance
  • What data generation option are realistically possible?
  • Dealing with the implication on PPP the re-registration process

Peter Campbell, Syngenta

1420

1445

Implementing scientific developments in Regulation 1107/2009

  • Commission role in scientific guidance document development
  • Focus areas for current guidance development
  • Status update on endocrine disruption criteria

Karin Nienstedt, DG SANTE

1445

15100

Industry view: Evolving science and impact on testing programmes

  • Opportunities to improve the focus of data and testing
  • EU vs international developments
  • Risk 21: An opportunity to shift the paradigm of safety assessment?

Tina Mehta, Dow

1510

1540

Panel discussion, with:

Jarlath Hynes, Humane Society International

1540

1600

Conference conclusions

1600

Close

Details

Start: 9 March 2016
09:00
End: 10 March 2016
16:00
ECPA & ECCA

Hotel Le Plaza Brussels, Brussels, Belgium


1000 Brussels
Belgium

Related documents

  • 01-march-conference-programme-rev31.doc